Stephanie Epstein Srulowitz is a partner in Weil’s U.S. Private Funds practice and is based in New York. Stephanie has worked on a variety of transactions, primarily representing private investment fund sponsors in connection with the formation, structuring and negotiation of their investment funds, as well as providing sophisticated advice regarding carried interest sharing and other economic and governance issues. She has also represented certain institutional investors in connection with their private fund investments, including private equity, real estate and other closed-end funds. In addition, Stephanie advises sponsors in connection with complex secondary transactions, including fund restructurings, continuation funds and purchases of portfolios of fund interests. She advises regularly with respect to co-investment structures and terms for her private equity clients, which include American Securities, Ascribe Capital, Berkshire Partners, CPP Investments, Crow Holdings, Graycliff Partners LP, IFM Management, Lee Equity Partners, Quad Partners, Strattam Capital, TPG, Tritium Partners and WindRose Health Investors.
Stephanie is recognized as a leading lawyer for Fund Formation by Chambers Global and Chambers USA, where clients note “she has a commercial mindset, she's talented” and “her fund knowledge is encyclopedic and she is an excellent resource.” She is recognized as an expert in Investment Funds by Expert Guides’ “Women in Business Law.” Stephanie is also recognized as a “Highly Regarded” lawyer for Private Equity Funds in the U.S. by IFLR1000 and is recommended for Private Equity Funds by Legal 500 US. She was recognized as a 2018 “Rising Star” for Asset Management by Law360 and the same year named “Best in Investment Funds” by Euromoney Legal Media Group in its inaugural Americas Rising Stars Awards.